BIOMAT Database Logo BIOMAT Database Logo

Detection of HIV-1 RNA in heparinized plasma of HIV-1 seropositive individuals. 1992

H Imai, and O Yamada, and S Morita, and S Suehiro, and T Kurimura
Department of Pathology, Osaka University, Japan.

The interference of reverse transcription by heparin was removed by heparinase. When the HIV-1 RNA in the presence of heparin was detected by a combination of reverse transcription and the polymerase chain reaction (PCR), heparinase treatment followed by removal of Ca2+ before the reverse transcription step permitted the efficient detection of HIV-1 RNA. Prior treatment with heparinase revealed HIV-1 RNA in 68% (13/19) of heparinized plasma samples from HIV-1 carriers, whereas only 26% (5/19) of the same specimens were positive without the heparinase step. Heparinase removed the inhibition of reverse transcription by heparin and is highly recommended when detecting low levels of viral RNA in heparinized plasma.

UI MeSH Term Description Entries
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

H Imai, and O Yamada, and S Morita, and S Suehiro, and T Kurimura
Detection of HIV-1 in seminal plasma and seminal cells of HIV-1 seropositive men.
December 1998, Journal of reproductive immunology,
H Imai, and O Yamada, and S Morita, and S Suehiro, and T Kurimura
Association of Cytokines With Exosomes in the Plasma of HIV-1-Seropositive Individuals.
June 2015, The Journal of infectious diseases,
H Imai, and O Yamada, and S Morita, and S Suehiro, and T Kurimura
Detection of human immunodeficiency virus type 1 (HIV-1) in urine cell pellets from HIV-1-seropositive individuals.
May 1992, Journal of clinical microbiology,
H Imai, and O Yamada, and S Morita, and S Suehiro, and T Kurimura
HIV-1 group N among HIV-1-seropositive individuals in Cameroon.
November 2000, AIDS (London, England),
H Imai, and O Yamada, and S Morita, and S Suehiro, and T Kurimura
Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates.
June 1991, AIDS (London, England),
H Imai, and O Yamada, and S Morita, and S Suehiro, and T Kurimura
IgG antibodies to HIV-1 in urine of HIV-1 seropositive individuals.
April 1988, Lancet (London, England),
H Imai, and O Yamada, and S Morita, and S Suehiro, and T Kurimura
Detection of HIV-1 RNA in vaginal secretions of HIV-1-seropositive women who have undergone hysterectomy.
August 1997, AIDS (London, England),
H Imai, and O Yamada, and S Morita, and S Suehiro, and T Kurimura
Direct detection of HIV RNA expression in seropositive subjects.
September 1988, Lancet (London, England),
H Imai, and O Yamada, and S Morita, and S Suehiro, and T Kurimura
Correlates of plasma HIV-1 RNA viral load among HIV-1-seropositive women in Dar es Salaam, Tanzania.
July 2002, Journal of acquired immune deficiency syndromes (1999),
H Imai, and O Yamada, and S Morita, and S Suehiro, and T Kurimura
Detection of low HIV-1 RNA levels in plasma.
February 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
Copied contents to your clipboard!